Zoetis

Zoetis Inc. is a global animal health company that discovers, develops, manufactures, and markets veterinary drugs and vaccines, with a focus on both livestock and companion animals. The company was a subsidiary of Pfizer, the world's largest drug maker, but became a fully independent company in 2013 following a spin-off. Zoetis is headquartered in Parsippany, New Jersey, United States, and operates in more than 100 countries. It is known for its wide range of products that aim to improve the health of animals and contribute to the overall well-being of the veterinary field.

History

Zoetis was founded as a result of Pfizer's decision to spin off its animal health division. The company made its debut as a publicly traded company on February 1, 2013, after raising $2.2 billion in its initial public offering (IPO), one of the largest IPOs by a U.S. company at that time. Since becoming independent, Zoetis has focused on expanding its product portfolio and global footprint through strategic acquisitions and research and development efforts.

Products and Services

Zoetis offers a broad range of products for animal health, including vaccines, anti-infectives, parasiticides, medicated feed additives, and other pharmaceuticals. The company's products cater to a wide variety of animals, including dogs, cats, horses, cattle, pigs, poultry, and fish. Zoetis is also involved in the development of diagnostic products, genetics tests, and precision animal health technologies.

Research and Development

Research and development (R&D) are central to Zoetis's operations. The company invests heavily in R&D to develop new products and improve existing ones. Its R&D efforts are focused on addressing the most pressing health challenges facing animals today, including infectious diseases, chronic conditions, and issues related to animal reproduction.

Global Presence

Zoetis has a significant global presence, with operations in over 100 countries and products sold in more than 45 countries. The company's global strategy includes tailoring its product offerings to meet the specific needs of animals in different regions, taking into account local diseases, farming practices, and regulatory environments.

Corporate Responsibility

Zoetis is committed to corporate responsibility, with initiatives aimed at enhancing animal welfare, supporting the veterinary profession, and minimizing its environmental impact. The company's corporate responsibility efforts also include supporting communities through educational programs and disaster relief efforts.

Financial Performance

As an independent company, Zoetis has shown strong financial performance, with consistent revenue growth and profitability. The company's financial success is attributed to its diverse product portfolio, global reach, and ongoing investment in R&D.

Challenges and Opportunities

The animal health industry faces several challenges, including regulatory hurdles, the emergence of antibiotic resistance, and the need for sustainable farming practices. However, Zoetis views these challenges as opportunities to innovate and develop solutions that contribute to the health and productivity of animals and the sustainability of the veterinary and agriculture industries.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

• 

  Logo of Zoetis

• 

  Zoetis Headquarters Building